Abstract:Fibromyalgia (FM) is a central disorder characterized by chronic pain, fatigue, insomnia, depression, and other minor symptoms. Knowledge about pathogenesis is lacking, diagnosis difficult, clinical approach puzzling, and patient management disappointing. We conducted a theoretical study based on literature data and computational analysis, aimed at developing a comprehensive model of FM pathogenesis and addressing suitable therapeutic targets. We started from the evidence that FM must involve a dysregulation of central pain processing, is female prevalent, suggesting a role for the hypothalamus-pituitary-gonadal (HPG) axis, and is stress-related, suggesting a role for the HP-adrenocortical (HPA) axis. Central pathogenesis was supposed to involve a pain processing loop system including the thalamic ventroposterolateral nucleus (VPL), the primary somatosensory cortex (SSC), and the thalamic reticular nucleus (TRN). For decreasing GABAergic and/or increasing glutamatergic transmission, the loop system crosses a bifurcation point, switching from monostable to bistable, and converging on a high-firing-rate steady state supposed to be the pathogenic condition. Thereafter, we showed that GABAergic transmission is positively correlated with gonadal-hormone-derived neurosteroids, notably allopregnanolone, whereas glutamatergic transmission is positively correlated with stress-induced glucocorticoids, notably cortisol. Finally, we built a dynamic model describing a multistable, double-inhibitory loop between HPG and HPA axes. This system has a high-HPA/low-HPG steady state, allegedly reached in females under combined premenstrual/postpartum brain allopregnanolone withdrawal and stress condition, driving the thalamocortical loop to the high-firing-rate steady state, and explaining the connection between endocrine and neural mechanisms in FM pathogenesis. Our model accounts for FM female prevalence and stress correlation, suggesting the use of neurosteroid drugs as a possible solution to currently unsolved problems in the clinical treatment of the disease.

Bimatoprost-induced periocular skin hyperpigmentation: histopathological study.

Re: "Acrorenal syndrome in a child with renal failure" [Akl, 1994].

Altered whole brain functional activity in patients with fibromyalgia

The puzzle of fibromyalgia between central sensitization syndrome and small fiber neuropathy: a narrative review on neurophysiological and morphological evidence

Non-Invasive Electric and Magnetic Brain Stimulation for the Treatment of Fibromyalgia

Neural indices of multimodal sensory and autonomic hyperexcitability in fibromyalgia

Functional Brain Network Mechanism of Hypersensitivity in Chronic Pain

Implication of intestinal microbiota in the etiopathogenesis of fibromyalgia: A systematic review

Exploration of Functional Connectivity Changes Previously Reported in Fibromyalgia and Their Relation to Psychological Distress and Pain Measures

Lower Functional Connectivity of the Periaqueductal Gray Is Related to Negative Affect and Clinical Manifestations of Fibromyalgia

Fibromyalgia and Irritable Bowel Syndrome Interaction: A Possible Role for Gut Microbiota and Gut-Brain Axis

Women with fibromyalgia: Insights into behavioral and brain imaging

Imaging Brain Mechanisms of Functional Somatic Syndromes: Potential as a Biomarker?

Right anterior insula is associated with pain generalization in patients with fibromyalgia

An Exploratory Clinical Study

Control of poliomyelitis in Kuwait.

Brain dysfunction in fibromyalgia and somatization disorder using proton magnetic resonance spectroscopy: a controlled study

Disruptive compensatory mechanisms in fibromyalgia syndrome and their association with pharmacological agents

Fecal Microbiota Transplantation Improves Clinical Symptoms of Fibromyalgia: An Open-Label, Randomized, Nonplacebo-Controlled Study

Replication of neural responses to monetary incentives and exploration of reward-influenced network connectivity in fibromyalgia

Fibromyalgia pathogenesis explained by a neuroendocrine multistable model